Emily Nieves

Co-Founder Delineate (YC W25) | MIT

Co-founder

Delineate· Winter 2025 🇺🇸 Cambridge, Massachusetts, United States

in LinkedIn

2024Co-founder· Delineate

Founder · since 2024

Company

Delineate

Role

Co-Founder & CEO

current

Stage

—

no public source

Raised

—

no public source

Based

Cambridge, Massachusetts, United States

current

Founder / co-founder — the company's markEmployee / research role

Source: LinkedIn work history

Profile coverage5 of 7 · missing posts, contact

Delineate

Agents for Accelerated Clinical Trial Design

Winter 2025

Experience

Career

Delineate
Co-founder
Co-Founder & CEO · Cambridge, Massachusetts, United States · 2024 – Present
2024
Massachusetts Institute of Technology
PhD Student in the Julia Lab · 2022 – Present
2022
Massachusetts Institute of Technology
PHD · 2021 – Present
2021
Pfizer
Quantitative Systems Pharmacology Intern · 2022
2022
AstraZeneca
Quantitative Clinical Pharmacology Intern · 2020 – 2021
2020
AstraZeneca
Quantitative Clinical Pharmacology Intern · Gaithersburg, MD · 2018
2018
University of Georgia College of Engineering
REU Nanobio Research Assistant · Athens, Georgia Area · 2017
2017

Bio

Co-founder at Delineate. Previously she was an MIT PhD Candidate in Biological Engineering and worked at Pfizer and AstraZeneca where she focused on applying AI to modeling and simulation for drug development optimization.